Position in IPSC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,009,065
+$233,356 QoQ
Shares Held
1,228,190
0.0% QoQ
Ownership
0.678%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#27
of 98 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $1,258,350,419 across 31 Biotechnology names. IPSC ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $482,682,924 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
16,035,240 | $300,019,340 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $63,062,250 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,045,000 | $52,597,400 | |
| 5 | NGNE |
Neurogene Inc.
|
1,545,361 | $48,601,603 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $46,332,000 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
665,000 | $36,575,000 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
843,857 | $25,180,692 |
All Filings in IPSC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,009,065 | 1,228,190 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,775,709 | 1,228,190 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,222,049 | 1,228,190 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $611,638 | 1,228,190 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $686,558 | 1,228,190 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,529,062 | 3,212,316 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,529,062 | 3,212,316 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,242,411 | 5,190,506 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,493,060 | 3,212,316 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,235,790 | 5,190,506 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $13,402,668 | 3,206,380 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,645,181 | 3,206,380 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,412,760 | 3,206,380 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,132,160 | 3,206,380 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,126,138 | 3,206,380 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,448,729 | 3,206,380 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $31,711,098 | 3,206,380 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,933,592 | 3,206,380 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $40,368,324 | 3,206,380 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $50,853,186 | 3,206,380 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $80,672,520 | 3,206,380 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $94,075,189 | 3,206,380 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||